Literature DB >> 3509765

Serum colony stimulating activity and colony forming cells in murine brucellosis: relationship to immunopathology.

C Cheers1, A M Young.   

Abstract

Intravenous injection of mice with Brucella abortus vaccine strain 19, results in a chronic infection, immunity to which is dependent on T cell activation of the macrophages. A major feature of the infection is splenomegaly characterized by massive numbers of macrophages. We report here investigations of the haemopoietic precursors of macrophages, the colony forming cells (CFC), and the growth factors, colony stimulating factors (CSF), controlling their production. Comparison was made amongst three mouse strains, CBA, BALB/c and C57B1/10, as well as the F1 (CBA x BALB/c), which differ in the degree of splenomegaly developed and their ability to rid themselves of infection. The proportion of colony forming cells in the spleen peaked 2 to 3 weeks after infection and was higher in those strains which developed stronger splenomegaly. On the other hand there was no relation between colony forming cells and ability to control infection. Serum CSF also peaked 2-3 weeks post infection, with similar titres in all mouse strains studied. Bone marrow exhibited an early loss of total cellularity after infection followed by recovery. There was a sharp peak in the proportion of colony forming cells in the bone marrow 2 weeks post infection. Spleen and bone marrow CFC and serum CSF all returned to normal levels before infection was resolved.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509765     DOI: 10.1016/0882-4010(87)90095-7

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

1.  Prophylaxis or treatment of experimental brucellosis with interleukin-1.

Authors:  Y F Zhan; E R Stanley; C Cheers
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Response of the murine hematopoietic system to chronic infection with Mycobacterium lepraemurium.

Authors:  M Resnick; E Fibach; M Lebastard; L Levy; H Bercovier
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

3.  Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice.

Authors:  A G Doyle; W J Halliday; C J Barnett; T L Dunn; D A Hume
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

4.  Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

5.  Production of colony-stimulating factors during pneumonia caused by Chlamydia trachomatis.

Authors:  D M Magee; D M Williams; E J Wing; C A Bleicker; J Schachter
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.